1887

Abstract

Point-of-care testing for infection may be ideal and useful because significant numbers of the cases will be seen as outpatients. Recently, a new immunochromatographic method (ICM) targeting ribosomal protein L7/L12 (RP-L7/L12) in pharyngeal swabs became available in Japan, although clinical data and basic information regarding efficacy and characterization of this ICM are limited. The present study examined the fate of RP-L7/L12 during growth and the correlation between concentration in clinical specimens and the sensitivity of the ICM test. The usefulness of the ICM was investigated in patients suspected of having pneumonia and upper respiratory tract infection (137 children and 39 adults). The limit of detection for the ICM test was 1.1×10 c.f.u. ml of . Bacterial production of RP-L7/L12 correlated positively with the viable concentration ; antigen was then degraded in culture broth, with an half-life of approximately 2 days. Five other spp. and 14 representative respiratory pathogens were ICM assay negative at bacterial concentrations of 10 c.f.u. ml. The clinical sensitivity and specificity of the ICM assay were 57.1 % (20/35) and 92.2 % (130/141), respectively, in comparison with bacterial culture. Clinical specimens containing ≥10 c.f.u. ml of burden were ICM positive in 13 of 18 cases (72.2 %). The ICM is a poorly sensitive but reasonably specific means for detecting infections.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000336
2016-10-18
2024-12-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/10/1105.html?itemId=/content/journal/jmm/10.1099/jmm.0.000336&mimeType=html&fmt=ahah

References

  1. Chourasia B. K., Chaudhry R., Malhotra P. 2014; Delineation of immunodominant and cytadherence segment(s) of Mycoplasma pneumoniae P1 gene. BMC Microbiol 14:108 [View Article][PubMed]
    [Google Scholar]
  2. Couturier M. R., Graf E. H., Griffin A. T. 2014; Urine antigen tests for the diagnosis of respiratory infections: legionellosis, histoplasmosis, pneumococcal pneumonia. Clin Lab Med 34:219–236 [View Article][PubMed]
    [Google Scholar]
  3. Howe J. G., Hershey J. W. 1983; Initiation factor and ribosome levels are coordinately controlled in Escherichia coli growing at different rates. J Biol Chem 258:1954–1959[PubMed]
    [Google Scholar]
  4. Ishiguro T., Takayanagi N., Yamaguchi S., Yamakawa H., Nakamoto K., Takaku Y., Miyahara Y., Kagiyama N., Kurashima K. et al. 2013; Etiology and factors contributing to the severity and mortality of community-acquired pneumonia. Intern Med 52:317–324[PubMed] [CrossRef]
    [Google Scholar]
  5. Izumikawa K., Izumikawa K., Takazono T., Kosai K., Morinaga Y., Nakamura S., Kurihara S., Imamura Y., Miyazaki T. et al. 2014; Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature. J Infect Chemother 20:181–185 [View Article][PubMed]
    [Google Scholar]
  6. Jomaa M., Kyd J. M., Cripps A. W. 2005; Mucosal immunisation with novel Streptococcus pneumoniae protein antigens enhances bacterial clearance in an acute mouse lung infection model. FEMS Immunol Med Microbiol 44:59–67 [View Article][PubMed]
    [Google Scholar]
  7. Kannan T. R., Hardy R. D., Coalson J. J., Cavuoti D. C., Siegel J. D., Cagle M., Musatovova O., Herrera C., Baseman J. B. 2012; Fatal outcomes in family transmission of Mycoplasma pneumoniae . Clin Infect Dis 54:225–231 [View Article][PubMed]
    [Google Scholar]
  8. Köhler G., Milstein C. 1975; Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497 [View Article][PubMed]
    [Google Scholar]
  9. Kolberg J., Høiby E. A., Lopez R., Sletten K. 1997; Monoclonal antibodies against Streptococcus pneumoniae detect epitopes on eubacterial ribosomal proteins L7/L12 and on streptococcal elongation factor Ts. Microbiology 143:55–61 [View Article][PubMed]
    [Google Scholar]
  10. Kornspan J. D., Tarshis M., Rottem S. 2011; Adhesion and biofilm formation of Mycoplasma pneumoniae on an abiotic surface. Arch Microbiol 93:833–836 [View Article]
    [Google Scholar]
  11. Li W., Liu Y., Zhao Y., Tao R., Li Y., Shang S. 2015; Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay. Sci Rep 5:15539 [View Article][PubMed]
    [Google Scholar]
  12. Liljas A. 1991; Comparative biochemistry and biophysics of ribosomal proteins. Int Rev Cytol 124:103–136[PubMed] [CrossRef]
    [Google Scholar]
  13. Markham P. F., Duffy M. F., Glew M. D., Browning G. F. 1999; A gene family in Mycoplasma imitans closely related to the pMGA family of Mycoplasma gallisepticum . Microbiology 145:2095–2103 [View Article][PubMed]
    [Google Scholar]
  14. Miyashita N., Kawai Y., Tanaka T., Akaike H., Teranishi H., Wakabayashi T., Nakano T., Ouchi K., Okimoto N. 2015; Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: comparison with real-time PCR. J Infect Chemother 21:473–475 [View Article][PubMed]
    [Google Scholar]
  15. Miyashita N., Kawai Y., Kato T., Tanaka T., Akaike H., Teranishi H., Nakano T., Ouchi K., Okimoto N. 2016; Rapid diagnostic method for the identification of Mycoplasma pneumoniae respiratory tract infection. J Infect Chemother 22:327–330 [View Article][PubMed]
    [Google Scholar]
  16. Morozumi M., Chiba N., Okada T., Sakata H., Matsubara K., Iwata S., Ubukata K. 2013; Antibiotic susceptibility in relation to genotype of Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae responsible for community-acquired pneumonia in children. J Infect Chemother 19:432–440 [View Article][PubMed]
    [Google Scholar]
  17. Niederman M. S. 2015; In the clinic: community-acquired pneumonia. Ann Intern Med 163:1–17 [View Article][PubMed]
    [Google Scholar]
  18. Postma D. F., van Werkhoven C. H., Huijts S. M., Bolkenbaas M., Oosterheert J. J., Bonten M. J. 2012; New trends in the prevention and management of community-acquired pneumonia. Neth J Med 70:337–348[PubMed]
    [Google Scholar]
  19. Prina E., Ranzani O. T., Torres A. 2015; Community-acquired pneumonia. Lancet 386:1097–1108 [View Article][PubMed]
    [Google Scholar]
  20. Samarawickrama A., Alexander S., Ison C. 2011; A laboratory-based evaluation of the BioStar Optical Immunoassay point-of-care test for diagnosing Neisseria gonorrhoeae infection. J Med Microbiol 60:1779–1781 [View Article][PubMed]
    [Google Scholar]
  21. Sawa T., Kimura S., Honda N. H., Fujita K., Yoshizawa S., Harada Y., Sugiyama Y., Matsuyama K., Sohka T. et al. 2013; Diagnostic usefulness of ribosomal protein L7/L12 for pneumococcal pneumonia in a mouse model. J Clin Microbiol 51:1–7 [View Article][PubMed]
    [Google Scholar]
  22. Tjhie J. H., van Kuppeveld F. J., Roosendaal R., Melchers W. J., Gordijn R., MacLaren D. M., Walboomers J. M., Meijer C. J., van den Brule A. J. 1994; Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections. J Clin Microbiol 32:11–16[PubMed]
    [Google Scholar]
  23. Torres A., Blasi F., Peetermans W. E., Viegi G., Welte T. 2014; The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis 33:1065–1079 [View Article][PubMed]
    [Google Scholar]
  24. Yamazaki T., Kuroki H., Itagaki T., Iwata S., Tateda K. 2015; Evaluation of a rapid antigen detection kit targeting L7/L12 ribosomal protein for Mycoplasma pneumoniae . Kansenshogaku Zasshi 89:394–399[PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.000336
Loading
/content/journal/jmm/10.1099/jmm.0.000336
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error